
J&J Proposes $5.5B Settlement to End Decade-Long Talc Litigation
Johnson & Johnson has proposed a $5.5 billion settlement to resolve approximately 76,000 lawsuits alleging its talc-based baby powder caused ovarian cancer. The deal, which requires acceptance by 95% of claimants, would pay $3 billion in 2027 with remaining funds disbursed after 2028. While J&J maintains the claims lack scientific merit, plaintiffs' attorneys describe the agreement as a fair resolution after years of legal battles and failed bankruptcy attempts.






